Public Health England published its annual 'Hepatitis C in the UK' report on 14th December 2020. This is the key national reporting document for hepatitis C and monitors the UK's progress towards its goal of eliminating the virus by 2030. This year's report includes details on the impact of COVID-19 on hepatitis C infection based on available data.
Resources
Commissioner
NHS England, CCGs and local authorities are all responsible for commissioning different parts of hepatitis C testing, treatment and care. Find here tools, templates and other relevant documents to assist commissioners with their responsibilities to ensure hepatitis C patients are diagnosed and receive high quality care.
Showing 71 to 80 of 398 resources
-
Public Health England Hepatitis C in the UK 2020 Report
UK, England, Northern Ireland, Scotland, Wales 14 Dec 2020 Reports & Research PDF
-
Summary report: Hepatitis C testing in primary care
This is the summary report of a webinar hosted by HCV Action on testing for hepatitis C in primary care in October 2020. The webinar featured presentations from the HepCATT study team and the team from King's College Hospital who reported on their work with GPs so far.UK, England 30 Nov 2020 Case study, Tools & Templates, Strategy & Planning PDF
-
Summary report: Hepatitis C in the justice system - going beyond prisons
This report summarises the presentations and discussions from the HCV Action webinar, 'Hepatitis C in the justice system - going beyond prisons', held on Friday 23rd October as part of the National Hepatitis C ODN Stakeholder Webinar series. The event focused in particular on providing support around hepatitis C for those making the transition from prison to the community.UK 17 Nov 2020 Reports & Research, Tools & Templates, Strategy & Planning PDF
-
Summary report: National Hepatitis C ODN Stakeholder Event 2020
Eighteen months on from the start of NHS England’s hepatitis C elimination deal, HCV Action’s annual ODN event, co-hosted with the British Viral Hepatitis Group, explored how the UK has progressed towards elimination. It particularly focused on overcoming the challenges posed by the significant disruption of Covid-19 on healthcare services. This year’s event was held as a half-day webinar due to coronavirus-related restrictions and welcomed 129 participants from almost all ODNs and partner services.England 30 Oct 2020 Reports & Research, Tools & Templates, Strategy & Planning PDF
-
Summary report: Mitigating the impact of COVID-19 on HCV testing
This is the written summary of a webinar held on 8th October on mitigating the impact of COVID-19 on HCV testing. The first part of the webinar consisted of three presentations: Overview of testing, before and after COVID-19 - Helen Hampton, Lead Clinical Nurse for Blood Borne Virus, We Are With You; Outreach testing during the COVID-19 lockdown - Julian Surey, Find and Treat Team; and Postal testing or self-testing - Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow LiveUK, England 30 Oct 2020 Case study, Tools & Templates, Strategy & Planning PDF
-
Webinar: Mitigating the impact of COVID-19 on hepatitis C testing
This is a recording of a webinar focusing on how services can mitigate the impact of COVID-19 on hepatitis C testing and find alternative ways to test people. The first part of the webinar consisted of three presentations: 1/ Overview of testing, before and after COVID-19 - Helen Hampton, Lead Clinical Nurse for Blood Borne Virus, We Are With You 2/ Outreach testing during the COVID-19 lockdown - Julian Surey, Find and Treat Team 3/ Postal testing or self-testing - Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow LiveUK 22 Oct 2020 Case study, Tools & Templates, Strategy & Planning Video
-
Summary report: Hepatitis C case-finding in under-served groups - October 2020
This report summarises the October 2020 HCV Action webinar on hepatitis C case-finding in under-served groups, which formed part of a week-long series of webinars centred around the National Hepatitis C ODN Stakeholder Event. The webinar focused on four under-served groups in particular: Gypsy, Roma and Travellers; migrants; sex-workers, and the South Asian community. The webinar featured contributions from the following speakers: • Beth Davies – Head of Service and Development (Dorset), EDP Drug & Alcohol Services • Dr Inês Campos-Matos – Head of Migration Health, Public Health EnglandUK 22 Oct 2020 Reports & Research PDF
-
HCV Action ODN Stakeholder Event 2020: A national perspective on elimination
These are the opening talks from this year's ODN Stakeholder Event from Mark Gillyon-Powell, Head of Programme for HCV Elimination, NHS England and Prof Graham Foster, National Clinical Lead for ODNs, NHS England. The talks gives a national overview on hepatitis C elimination efforts in England and how COVID-19 has impacted these. Professor Guruprasad Aithal, President of the British Association for the Study of the Liver (BASL) chaired the event. We will be publishing a written summary of the other presentations from this event soon.England 07 Oct 2020 Other, Strategy & Planning Video
-
Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2020 report
The 2020 edition of the Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID contains a number of relevant updates on hepatitis C among injecting drug users, including: • The proportion of UAM participants with antibodies to hepatitis C (HCV) (i.e. ever infected) who have markers of chronic infection (RNA) has decreased from 58% in 2011 when it was first measured to 42% in 2019; this corresponds with the timing of the scale-up of direct acting antiviral treatment against HCV among PWIDUK 06 Oct 2020 Reports & Research PDF
-
Understanding the Sexual Health and Blood Borne Virus Risk Behaviours of Defined 'at risk' Groups
This report outlines the findings of research with drug users and the staff that support them related to harms associated with chemsex, transactional sex; and the use of image and performance enhancing drugs (IPEDs). Twos aims of the report were to describe the risk-taking behaviours in relation to drug taking, sexual health and transmission of BBV (blood borne virus) of the three target groups and inform the development of a training programme for services providers on sexual health and blood borne viruses for the three defined groups.Scotland 07 Sep 2020 Reports & Research PDF